Physician profile
William H Johnston
NPI 1427017789
$2,396.02
in general payments reported to CMS, 2019-2025
27 companies · $513 in 2025
The $513 reported for 2025 was more than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,109 · 2020: $238 · 2021: $61.15 · 2023: $250 · 2024: $225 · 2025: $513.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $687 · Food and Beverage: $301.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $686.90 |
| Food and Beverage | $300.62 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ethicon INC. | $686.90 | 2024-2025 | |
| Astellas Pharma US INC | $366.67 | 2019-2021 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $274.05 | 2019-2023 | Jardiance |
| Astrazeneca Pharmaceuticals LP | $189.52 | 2019 | |
| Janssen Pharmaceuticals, INC | $140.99 | 2019-2020 | |
| Novo Nordisk INC | $96.27 | 2019-2020 | |
| Pfizer INC. | $91.89 | 2019-2021 | |
| Amgen INC. | $74.97 | 2019-2020 | |
| Roche Diagnostics Corporation | $59.78 | 2019 | |
| Abbott Laboratories | $40.87 | 2020 | |
| Lilly USA, LLC | $38.59 | 2019 | |
| Ironwood Pharmaceuticals, INC | $33.02 | 2019-2020 | |
| Teva Pharmaceuticals USA, INC. | $31.85 | 2019 | |
| Novartis Pharmaceuticals Corporation | $31.42 | 2019-2020 | |
| Sanofi-Aventis U.S. LLC | $31.19 | 2019 |
Show all 27 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Palette Life Sciences, INC. | $29.75 | 2023 | |
| Dendreon Pharmaceuticals LLC | $29.63 | 2025 | Provenge |
| Takeda Pharmaceuticals U.S.A., INC. | $27.44 | 2019 | |
| Sun Pharmaceutical Industries INC. | $21.35 | 2024 | |
| Ironshore Pharmaceuticals INC. | $16.01 | 2020 | |
| Glaxosmithkline, LLC. | $15.98 | 2019 | |
| Ethicon US, LLC | $15.80 | 2019 | |
| Allergan, INC. | $13.70 | 2020 | |
| E.R. Squibb & Sons, L.L.C. | $11.67 | 2020 | |
| Merck Sharp & Dohme LLC | $11.43 | 2019 | |
| Amarin Pharma, INC. | $11.20 | 2020 | |
| Janssen Biotech, INC. | $4.08 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw William Johnston listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.